TONIX PHARMACEUTICALS Trademark

Trademark Overview

On Thursday, April 30, 2020, a trademark application was filed for TONIX PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the TONIX PHARMACEUTICALS trademark a serial number of 88896150. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, January 16, 2024. This trademark is owned by TONIX PHARMACEUTICALS, INC.. The TONIX PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
tonix pharmaceuticals

General Information

Serial Number88896150
Word MarkTONIX PHARMACEUTICALS
Filing DateThursday, April 30, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, January 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 4, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Disclaimer with Predetermined Text"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTONIX PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChatham, NJ 07928
Party NameTONIX PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Trademark Events

Event DateEvent Description
Wednesday, January 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 16, 2024SOU EXTENSION 5 GRANTED
Friday, December 22, 2023SOU EXTENSION 5 FILED
Tuesday, January 16, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 9, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 9, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, December 22, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 26, 2023SOU EXTENSION 4 GRANTED
Monday, June 26, 2023SOU EXTENSION 4 FILED
Monday, June 26, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 27, 2022SOU EXTENSION 3 GRANTED
Tuesday, December 27, 2022SOU EXTENSION 3 FILED
Tuesday, December 27, 2022SOU TEAS EXTENSION RECEIVED
Friday, July 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 29, 2022SOU EXTENSION 2 GRANTED
Wednesday, June 29, 2022SOU EXTENSION 2 FILED
Wednesday, June 29, 2022SOU TEAS EXTENSION RECEIVED
Saturday, July 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 1, 2021SOU EXTENSION 1 GRANTED
Thursday, July 1, 2021SOU EXTENSION 1 FILED
Thursday, July 1, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 29, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 4, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 4, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 14, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 30, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 30, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, March 30, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 30, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, March 30, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 5, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 5, 2021NON-FINAL ACTION E-MAILED
Friday, March 5, 2021NON-FINAL ACTION WRITTEN
Friday, February 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 12, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 12, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 13, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 13, 2020NON-FINAL ACTION E-MAILED
Thursday, August 13, 2020NON-FINAL ACTION WRITTEN
Friday, July 24, 2020ASSIGNED TO EXAMINER
Wednesday, May 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 4, 2020NEW APPLICATION ENTERED

Related Keywords

pharmaceuticals tonix system disorders treatment respiratory pharmaceutical genitourinary metabolic immune preparations dysfunction